Cargando…
Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
Autores principales: | Fischer, D, Veldman, A, Schloesser, RL, Boehles, HJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301551/ http://dx.doi.org/10.1186/cc1995 |
Ejemplares similares
-
Predictive factors of mortality in polytrauma patients with life threatening pelvic hemorrhage after transarterial embolization (TAE)
por: Hagiwara, A, et al.
Publicado: (2002) -
Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003) -
Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
por: Bonadona, A, et al.
Publicado: (2002) -
Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison
por: Böhm, Ernst, et al.
Publicado: (2011) -
Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system organ failure and acute upper gastrointestinal bleeding
por: Milanov, S, et al.
Publicado: (2003)